advantage 2 pcr enzyme system - takara1].pdf · 2017-09-12 · protocol no. pt3281-1 clontech...
TRANSCRIPT
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 2 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
Table of Contents
I. Introduction 3
II. List of Components 6
III. Additional Materials Required 7
IV. General Considerations 9
A.PrimerDesign 9
B.TemplateQuality 9
C.AmpliconSize 9
D.BackgroundAmplification 10
E.GoodPCRPractices 10
F.AdditionalConsiderations 11
V. Advantage® 2 PCR Procedure 12
A.ControlPCRReactions 12
B.RecommendedCyclingParametersforallAdvantage2PCRProducts 13
C.RecommendationsforElectrophoresis 14
D.Using10XAdvantage2SAPCRBuffer 14
VI. Troubleshooting Guide 16
VII. References 20
VIII. Related Products 20
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 3
Advantage® 2 PCR Enzyme System User Manual
I. Introduction
TheAdvantage® 2 Polymerase MixandAdvantage® 2 PCR Kit(whichincludesthePolymeraseMix)produceefficient,accurate,andconvenientamplificationofDNAfromanytemplate.The Advantage 2 Polymerase Mix is comprised of TITANIUM™ Taq DNAPolymerase—anuclease-deficientN-terminaldeletionofTaqDNApolymeraseplus TaqStart™Antibody to provide automatic hot-start PCR (Kellogg et al.,1994)—andaminoramountofaproofreadingpolymerase.TITANIUMTaqprovidesthemostsensitiveandrobustcapabilitiesofanyTaq-de-rivedpolymerase.ItsincreasedsensitivityandrobustnatureareespeciallyusefulforamplifyingawidesizerangeofDNAfragments,cDNAsofraretranscripts,orproductsfromcomplextemplates.ThehigheryieldsandincreasedsensitivitythatTITANIUMTaqprovidestranslateintotwomajoradvantagesoverconventionalpolymerases.First,targetscanbeamplifiedusingfewerPCRcycles,savingtimeandloweringbackgroundinanygivenexperiment.Second,insituationswheretheamplificationtargetispresentatextremelylowlevels(e.g.,amplifyingararecDNAinanRT-PCRexperimentordetectingviralnucleicacid),thehighsensitivityobtainedwithTITANIUMTaqallowssuccessfulamplificationofyourtargetwhereotherpolymerasesfail.TITANIUMTaqallowsyoutoperformPCRwithouttediousbufferoptimization.Inanygivenreaction,TITANIUMTaqtoleratesawiderangeofMg2+concentrationsresultinginhigheryields,especiallyforlongeramplicons.MagnesiumisalreadyincludedatasetconcentrationintheAdvantage 2 PCR Buffer,eliminatingtheneedtoaddMg2+asaseparatecomponentduringreactionsetup.Incontrast,nativeTaqpolymeraseonlyfunctionswelloveranarrow[Mg2+]range,anddif-ferentreactionsmayrequiredifferentconcentrationsofMg2+.ByeliminatingtheneedtoperformexperimentsfordeterminingtheoptimalMg2+concentration,TITANIUMTaqsavesconsiderabletimeandeffort.Incaseswherebackgroundamplification isaproblem,werecommendtheuseof10XAdvantage®2SAPCRBuffer.The10X Advantage® 2 SA PCR Buffer,availableseparately(Cat.No.639147&639148),hasbeenoptimizedforapplicationsusinggenomicDNA,andinparticularwithproductslessthan1-2kb.WehavefoundyieldstobecomparabletothatobtainedwithAdvantage2PCRBufferforrelativelysmallamplicons;however,foramplicons>2kb,werecommendtheuseoftheAdvantage2PCRBufferforbestresults.The10XAdvantage2SAPCRBuffercontainsMg2+ataconcentra-tionoptimizedformostapplications,particularlythoseutilizingagenomicDNAtemplate.Inaddition,theAdvantage2SAPCRBufferisrecommendedwhenbackgroundamplificationispresent,whichmaysometimesresultasaby-productofthesensitivityandrobustnessoftheAdvantage2PolymeraseMix.
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 � Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
I. Introduction continued
The Advantage® Polymerase Systems
ThesimultaneoususeoftwodifferentDNApolymerases(primaryandproofread-ing)inaPCRreactionallowsamplificationofsignificantlylongerfragmentsinaprocessknownaslongandaccuratePCR(orlong-distancePCR[LDPCR];Barnes, 1994; Cheng et al., 1994). However, the usefulness of two-enzymesystemsisnotlimitedtoLDPCR.Infact,theefficiencyofmost PCRreactionscanbesignificantlyimprovedbyusingthetwo-enzymecombination.TheAdvantage2systemoffersthreeprimarybenefitsoverconventional,single-polymerasePCR: — Increased range. Whereas the upper limit of conventional PCR us-
ingaTaqpolymerase is~3kb(andmuch lower inmanyapplications),Advantage2givesconsistentandefficientamplificationsofupto18kbormorewhenusingtwonondegenerateprimersofsufficientlengthtoamplifyanabundant,noncomplextemplate.Itcanalsoamplifyhigh-complexity(i.e.,genomic)DNAtemplatesupto6kb.Theabsoluteupperlimitinanyparticularapplicationwilldependontheparticularprimers,thetemplateused,andotherexperimentalvariables.
—Increased fidelity.Theinclusionofaminoramountofaproofreadingpoly-meraseresultsinanerrorratethatis3-foldlowerthanthatofconventionalPCRusingTaqalone(Barnes,1994;Freyet al.,1995;Nelsonet al.,1995).Inourstudies,Advantage2exhibitsanerrorrateof25errorsper100,000bpafter25PCRcycles.Notethatthepresenceoforganicsolventsorsaltsinthereactioncandecreasefidelity.Highfidelityisaparticularlyimportantfeaturewhentheamplificationproductswillbeusedinsubsequentexperi-ments(e.g.,cloning,sequencing,functionalassays,expressionsystems,etc.).
—Increased efficiency and greater yields.WhilerangeandfidelityarethemostcommonlynotedaspectsoflongandaccuratePCR,theuseofatwo-polymerasesystemalsoincreasestheefficiencyandyield—andthereforethesensitivity—ofall PCRassays,evenfortemplatesthatarewellwithintherangeofconventionalPCR.WhileDNApolymeraseswithproofread-ingactivityofferbetteraccuracythanLDPCRmethodswhenusedalone,theylacktheincreasedefficiencyandsize-rangeflexibilitypossiblewithAdvantage2systemforlongandaccuratePCR.
Automatic hot start with TaqStart™ Antibody
TheAdvantage 2 system contains built-in, hot-start PCR from TaqStartAn-tibody included in the polymerase mix. Antibody-mediated hot start usingTaqStartAntibodyhasbeenshowntosignificantly improvetheefficiencyandspecificityofPCRamplificationsbyreducingbackgroundDNAsynthesis(Kellogget al.,Clontechniques,1994;Kellogget al.,BioTechniques,1994).Specifically,thisantibodyreducesoreliminatesnonspecificamplificationproductsandprimer-dimerartifactscreatedpriortotheonsetofthermalcycling.
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 5
Advantage® 2 PCR Enzyme System User Manual
I. Introduction continued
TaqStartisaneutralizingmonoclonalantibodythatrecognizesbothnativeTaqandN-terminaldeletionssuchasTITANIUMTaq.TheantibodyinhibitsenzymaticactivityduringPCRreactionsetupatambienttemperatures.Polymeraseactivityisrestoredattheonsetofthermalcyclingbecausetheantibodyisdenaturedathightemperatures.Thelossofinhibitioniscompleteandirreversible,sothepolymeraseregainsitsfullenzymaticactivityforPCR.
Besides increased specificity and sensitivity, the built-in hot start in theAdvantage2PolymeraseMixoffersconvenience.Othermethodsofhotstartrequireextrastepssuchas theadditionandpremeltingofwaxbeadsor theadditionofacriticalcomponentaftertheinitialdenaturation.Theseextrastepsare inconvenient and introduceapotential sourceof cross-contamination. Incontrast,TaqStartprovidesautomatichot-startPCRwithvirtuallynoriskofcross-contamination.Thus,TaqStartAntibodyprovidesalltheadvantagesofhot-startPCRwithnoneofthedisadvantagesofotherhot-startmethods.TheantibodycomesalreadyincludedintheAdvantage2PolymeraseMix;thereisnoneedtoadditasaseparatereagentduringPCRsetup.
Recommended uses for Advantage® 2 Products
The Advantage 2 Mix and Kit are the recommended polymerase systemsfor use in applications involving RACE, RT-PCR, cDNA synthesis and li-brary construction, cDNA subtraction and differential display, high-perfor-mance cloning, and RNA fingerprinting. TheAdvantage 2 System has beenoptimized for use with all Clontech PCR-based application kits, includingSMART™cDNALibraryConstruction,SMART™PCRcDNASynthesis,SMART™RACEcDNAAmplification,ClontechPCR-Select™SubtractionKits,andMara-thon® cDNA Amplification, including GenomeWalker™ Kits, we recommendAdvantage® Genomic Kits. See Related Products (Section VIII) for orderinginformation.
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 6 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
Advantage® 2 PCR Kit (Cat.Nos.639207&639206)Storeallcomponentsat–20°C.Enoughreagentsaresuppliedfor30or100PCRreactionsof50µleach.
639207 639206 30 rxns 100 rxns
• 30 µl 100 µl 50X Advantage® 2 Polymerase Mix IncludesTITANIUMTaqDNAPolymerase,asmallamount
of proofreading polymerase, and TaqStart Antibody(1.1µg/µl)inthefollowingstoragebuffer:
•200 µl 600 µl 10X Advantage® 2 PCR Buffer
•200 µl 600 µl 10X Advantage® 2 SA PCR Buffer• 50 µl 120 µl 50X dNTP Mix(10mMeachofdATP,dCTP,dGTP,anddTTP;
finalrxnconcentration:0.2mMeach)
• 30 µl 100 µl Control DNA Template(100ng/µl) CalfThymusDNA
• 30 µl 100 µl Control Primer Mix(10µMeach) 5’primer5’–GCAACTGCAGGAAGAGCAAGAAATGCA–3’
3’primer5’–TGGCACGGCCATAAGAGGTAGATGTCA–3’
• 2.5 ml 5.0 ml PCR-Grade Water
II. List of Components
Concentrationin50Xmix Component
Finalrxnconcentration
50% Glycerol 1%
15mM Tris-HCl(pH8.0) 0.3mM
75mM KCl 1.5mM
0.05mM EDTA 1.0µM
Concentrationin10Xmix Component
Finalrxnconcentration
400mM Tricine-KOH(pH8.7at25°C)
40mM
150mM KOAc 15mM
35mM Mg(OAc)2 3.5mM
37.5µg/ml BSA 3.75µg/ml
0.05% Tween20 0.005%
0.05% Nonidet-P40 0.005%
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 �
Advantage® 2 PCR Enzyme System User Manual
Advantage® 2 Polymerase Mix (Cat.Nos.639201&639202)Storeallcomponentsat–20°C.Enoughreagentsaresuppliedfor100or500PCRreactionsof50µleach.
639201 639202 100 rxns 500 rxns
• 100 µl 5 x 100 µl 50X Advantage 2 Polymerase Mix Seepage6forcomponentconcentrations.
• 600 µl 5 x 600 µl 10X Advantage 2 PCR Buffer Seepage6forcomponentconcentrations.
• 600 µl 5 x 600 µl 10X Advantage 2 SA PCR Buffer
10X Advantage® 2 SA PCR Buffer (Cat.No.639147&639148)Storeat–20°C.Enoughbufferissuppliedfor240or2,000PCRreactionsof50µleach.
639147 639148 240 rxns 2,000 rxns
• 2 x 600 µl 10 ml 10X Advantage® 2 SA PCR Buffer Bufferalone.
III. Additional materials required
Thefollowingreagentsarenotsupplied.
• Thermal cycler
• Dedicated pipettors (1–2µl,1–10µl,1–20µl,20–200µl,200–1000µl)• PCR pipette tips suitableforusewiththeabovepipettorsandpreferably equippedwithhydrophobicfilters.• DNA size markers (SeeSectionV.D.)• 5X Stop/loading buffer(Sambrook&Russell[2001]providesseveralreci pes)
II. List of Components continued
Concentrationin10Xmix Component
Finalrxnconcentration
100mM Tris-HCl(pH8.5) 10mM
500mM KCl 50mM
20mM MgCl2 2mM
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 8 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
• PCR-grade water AvoidusingautoclavedH2Obecauserecycledsteaminsomeautoclaves canintroducecontaminantsthatmayinterferewithPCR.• PCR reaction tubes • [Optional]:Mineral oil(WerecommendSigmaCat.No.M3516.)
IfyouhavepurchasedtheAdvantage 2 Polymerase Mixalone(Cat.Nos.639201&639202),youwillneedthefollowing:• dNTPmix• appropriatecontroltemplateandprimers
IfyouhavepurchasedtheAdvantage 2 SA PCR Bufferalone(Cat.Nos.639147&639148),youwillneedthefollowing:• heat-stableDNAPolymerase• dNTPmix• appropriatecontroltemplateandprimers
III. Additional Materials Required continued
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 �
Advantage® 2 PCR Enzyme System User Manual
A. Primer Design Primerdesignisthesingle largestvariable inPCRapplicationsandthe singlemostimportantfactorindeterminingthesuccessorfailureofPCR reactions.Always check and recheck your primer design before construct- ing or ordering primers. Length and G-C content: TheAdvantage 2 system can be used in a widevarietyofPCRapplications,andtheconstraintsonprimerdesignwill varyfromoneapplicationtothenext.Ingeneral,however,primersshould haveaTmofapproximately70°Ctoachieveoptimalresultsinatwo-step cyclingprogramwitha68°Cannealing/extensionstep.Therefore,when- everpossible,primersshouldbeat least 22nucleotides(nt)long(25–30- mersarepreferred)andshouldhaveaG-Ccontentof45–60%.Further- more,the3’-terminalendsofeachprimershouldnotbecomplementaryto eachotherandshouldcontainalowG-Ccontent.
B. Template Quality Because PCR amplification proceeds exponentially, many conventional PCRapplicationsworkwellwithtemplatesofaverageorevenlowquality. In many applications (such as screening cDNA inserts with LD Insert Screening Amplimers), long and accurate PCR with Advantage 2 will alsotolerateawiderangeoftemplatequality. However, the longer or more complex the target, the more important templatequalitybecomes.Thisisbecausethenumberofunnicked,full- length targetsdecreasesas the target length increases,sopoor-quality DNA will have very few large, unnicked targets. Furthermore, some depurinationoccurswhenDNAisdenaturedduringthermalcycling,and thiscanleadtotruncatedproducts.Therefore,itisparticularlyimportantto prepare high-quality, high molecular-weight DNA when amplifying largetargets. Templatequalityisalsoimportantwhenthehighestpossiblesensitivityis needed. In cDNA applications such as RACE and RT-PCR protocols, incomplete reverse transcription can lead to an absence of product, truncatedproducts,oramixoftruncatedandfull-lengthproduct,resulting inasmearedbandonagel.Thisproblemcanbeminimizedbyensuringthat yourstartingmaterial isof thehighestquality.For5’and3’RACEand generalPCRfromcDNA,youcanensurethequalityofyourcDNAbyusing Marathon-ReadycDNAfromClontech.
C. Amplicon Size Yieldsareunaffectedwhenamplifyingproductslessthan2kb,whetherthe 10X Advantage 2 SA PCR Buffer or the Advantage 2 PCR Buffer is used. We recommend initial use of the 10XAdvantage 2 PCR Buffer; however,ifaproblemarises,inparticularwithampliconslessthan2kbin length, then we recommend switching to the 10X Advantage 2 SA PCRBuffer.Forproductsgreaterthan2kb,werecommendtheoriginal
IV. General Considerations
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 10 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
IV. General Considerations continued
Advantage2PCRBufferbeused(ratherthantheSAPCRBuffer). D. Background Amplification Due to the sensitivity and robustness of theAdvantage 2 Polymerase Mix, non-specific background amplification may sometimes result. The 10XAdvantage2ShortAmplicon(SA)PCRBufferhasbeenspecifically engineeredtoaddressthisissue.Werecommendtheuseofthisbufferin thoseapplicationswheresomebackgroundamplificationmayresult. E. Good PCR Practices 1.Preparereactionswithdedicatedpipettorsinadedicatedworkspace DuetothetremendousamplificationpowerofPCR,minuteamounts
ofcontaminatingDNAcanproducenonspecificamplification;insomeinstances,contaminantscancauseDNAbandsevenintheabsenceofaddedtemplateDNA.Werecommendthatyouusesmallaliquotsofstartingmaterialtoavoidcontaminatingyourstocks.WhenperformingPCR,youshouldwearglovesandsetupyourreactionsinadedicatedlabareaornoncirculatingcontainmenthoodusingdedicatedpipettors,PCRpipettetipswithhydrophobicfilters,anddedicatedsolutions.Wealsorecommendsettingupanegativecontrolreactionthatdoesnotcontainanytemplate.Finally,performpost-PCRanalysisinaseparateareausingaseparatesetofpipettors.
2.Pipetting Because of the small volumes used in PCR experiments and the
potential for tube-to-tube variation, careful pipetting technique isextremelyimportant.Alwaysbesurethatnoextrasolutionisontheoutside of the pipette tip before transfer. When adding solution toa tube, immerse the tip into the reaction mixture, deliver the con-tents from the pipette tip into the mixture, and pipet up and downseveraltimes.
3.UseaMasterMix Assembling a Master Mix, which contains the appropriate volumes
ofall reagents required formultiplePCRreactions,saves timeandgreatlyreducestube-to-tubevariation.Ifmultipletemplatesarebeingtestedwiththesameprimers,includetheprimersintheMasterMix.Ifonetemplateisbeingtestedwithmultipleprimersets,includethetemplateintheMasterMix.Ifyouaresettingupseveralsetsofparallelsamples,assemblemultipleMasterMixes(e.g.,eachwithadifferentsetofprimers).The Master Mix should be thoroughly mixed before use (i.e., vortexed without bubbling).
4.Alwaysincludepositiveandnegativecontrols(i.e.,H2OinsteadofDNAtemplate).
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 11
Advantage® 2 PCR Enzyme System User Manual
F. Additional Considerations 1.TouchdownPCR “Touchdown” PCR can significantly improve the specificity of many
PCRreactionsinawidevarietyofapplications(Donet al.,1991;Roux,1995).Briefly,touchdownPCRinvolvesusinganannealing/extensiontemperaturethatisseveraldegrees(typically3–10°C)higherthantheTmoftheprimersduringtheinitialPCRcycles(typically5–10cycles).Theannealing/extensiontemperatureisthenreducedtotheprimerTmfortheremainingPCRcycles.
2.TaqStartAntibodyprovidesautomatichotstartPCR Theuseofamanualhotstartorwaxbead-basedhotstartisnotrequired
whenusingtheAdvantage2system.AsdiscussedintheIntroduction,hotstartisautomaticbecausetheenzymemixalreadycontainsTaqStartAntibody.
3.Half-life Thehalf-lifeofTITANIUMTaqdependsonthespecificreactioncondi-
tionsused,butgenerallyrangesfrom20–40minat95°C. 4.Useofadditives TaqStartAntibody bindsTITANIUM Taq DNA Polymerase with high
affinityundertheconditionsdescribedinthisprotocol.Theadditionof2–5%DMSOwillnotinterferewithTaqStartantibodyfunctionandmayimproveresultsinsomeinstances.However,theadditionofformamideorothercosolventsmaydisruptTaqStartantibodyfunction.Further-more,excessiveglycerol,solutes(e.g.,salts),pHextremes,orotherdeviationsfromtherecommendedreactionconditionsmayreducetheeffectivenessoftheantibodyand/orDNApolymerases.
5.Advantage2PolymeraseMixisnotintendedforcertainapplications Because of the improved fidelity from long and accurate PCR,
Advantage2isnotrecommendedformutagenesisprotocolsinvolvingso-called“sloppy”PCR.
6.T/ACloning TITANIUM Taq PCR products are compatible with T/A cloning
methods. However, for optimal ligation efficiencies, we recommendthatyouusePCRproductsimmediately(<1day)afteramplification.The single3’A-overhangson thePCRproductswill degradeovertime,reducingtheefficiency.Forbestresults,pleaseobservetheT/AcloningtipsinSectionV.C.
IV. General Considerations continued
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 12 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
PLEASE READ THE ENTIRE PROTOCOL BEFORE STARTING.
A. Control PCR Reactions ThefollowingcontrolPCRreactionsshouldbeperformedinparallelwith
yourexperimentstoensurethattheAdvantage2PolymeraseMixiswork-ingproperly.ApositivecontroltemplateandprimersareprovidedintheAdvantage2PCRKit.WhenusingtheAdvantage2PolymeraseMixwithourotherPCR-basedapplicationskits,usethepositivecontrolsprovidedwiththosekits.
1.Place all components on ice and allow to thaw completely. Mixeachcomponentthoroughlybeforeuse.
2.CombinethefollowingreagentsinaPCRtube.
3.Mixwellandspintubebrieflytocollectalltheliquidinbottomoftube. 4.[Optional]: Ifyour thermalcyclerdoesnothavea “hot lid”,add1–2
dropsofmineraloiltopreventevaporationduringcycling.Agood“seal”ofmineraloilshouldhaveawell-definedmeniscusbetweenthetwophases.CapthePCRtubesfirmly.
5.Commencethermalcyclingusingthefollowingparameters: •95°Cfor1min •30cycles* 95°Cfor15sec 68°Cfor3min
*30cycleswitha3-minannealing/extensiontimeissufficientforamplificationofthepositivecontroltemplateprovidedinthekit.Othertemplatesmayrequiremoreorlesscyclesanddifferentannealing/extensiontimes(SeeSectionV.B.).
6.Transfera5µlsampleofyourPCRreactiontoafreshtubeandadd1µlof5Xstop/loadingbuffer.Analyzeyoursample(s),alongwithsuitableDNAsizemarkers,byelectrophoresisona1.2%agarose/EtBrgel.
Expected results: Ifyouareusingthepositivecontrolreagentsprovidedinthekit,thereactionshouldproduceasinglemajorfragmentof3.5kb,
V. Advantage® 2 PCR Procedure
PositiveControl
NegativeControl
40µl 41µl PCR-GradeWater
5µl 5µl 10XAdvantage2PCRBuffer
1µl --- ControlDNATemplate(100ng/µl)
2µl 2µl ControlPrimerMix(10µMea.)
1µl 1µl 50XdNTPMix(10mMea.)
1µl 1µl 50XAdvantage2PolymeraseMix
50 µl 50 µl Total volume
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 13
Advantage® 2 PCR Enzyme System User Manual
derivedfromthegeneforthebovinepancreatictrypsininhibitor.Nobandsshouldbegeneratedinthenegative(i.e.,noDNAtemplate)control.
B. Recommended Cycling Parameters for all Advantage® 2 PCR Products
UsethefollowingguidelineswhensettingupyourinitialexperimentswiththeAdvantage2system.Thesearegeneralguidelines—theoptimalpa-rametersmayvarywithdifferentthermalcyclersandwilldependonyourparticularprimers,template,andotherexperimentalvariables.
Notes: • WhenusingtheAdvantage2PolymeraseMixwithourotherPCR-based
application kits (suchasSMARTcDNALibraryConstruction,SMARTPCRcDNASynthesis,ClontechPCR-SelectSubtractionKits,MarathoncDNA Amplification, or Marathon-Ready cDNAs, use the parametersrecommendedintheprotocolforthatkit.
• Ifyou intend tocaptureyourPCRproductbyT/Acloning,werecom-mend thatyouaddanadditional10-minextensionat70°C,and thenimmediatelycloneorfreezethePCRproduct.Donotstorethereactionat4°C.Thesestepswillhelpensuretheincorporationandpreservationof3’A-overhangs.
Target Cycle Size Parameters
<1kb: •95°Cfor1min •25–35cyclesa
95°Cfor30secb
68°Cfor1minc
•68°Cfor1mind
1–5kb: •95°Cfor1min •25–35cyclesa
95°Cfor30secb
68°Cfor3minc
•68°Cfor3mind
5–9kb: •95°Cfor1min •25–35cyclesa
95°Cfor30secb
68°Cfor6minc
•68°Cfor6mind
V. Advantage® 2 PCR Procedure continued
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 1� Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
10–20kb: •95°Cfor1min •25–35cyclesa
95°Cfor30secb
68°Cfor12minc
•68°Cfor12mind
a 25 cycles for multiple-copy genes or medium-to-high abundance cDNAs; 30–35cyclesforsingle-orlow-copy-numbergenesorrarecDNAs.Formostapplications,weprefertwo-stepcycles(denaturationatT1followedbyannealingandextensionatT2)insteadofthree-stepcycles(denaturationatT1followedbyannealingatT2followedbyextensionatT3).Three-stepcycleswillbenecessarywhentheTmoftheprimersislessthan60–65°Candincertainspecialprotocols.
b Usetheminimalpossibledenaturationtime.Insomecases,betterresultsmaybeob-tainedbymodifyingthedenaturationstep(94°Cfor15sec).ExposureofDNAtohightemperaturescausessomedepurinationofsingle-strandedDNAduringdenaturation,whicheventuallyleadstostrandscission.Hightemperaturealsoleadstograduallossofenzymeactivity.Minimizingdenaturationtimeisparticularlyimportantinexperimentswithverylargetemplateswheretotalcyclingtimecanexceed12hr.
c Usethemaximumpossibleannealing/extensiontemperature.See“Notea”.Someresearchersprefertouseanannealing/extensiontimeequaltotheexpectedtargetsize(inkb)plustwominutes.Werecommendusing1minperkbofexpectedtarget.
d Optional:Thisfinalextensionmayreducebackgroundinsomecases.
C. Recommendations for Electrophoresis Werecommendthatyoutransfera5µlsampleofyourPCRreactionto
afreshtubeandadd1µlof5Xstop/loadingbuffer.Placetheremaining45µlofthereactionmixtureonice;itcanbesubjectedtofurthercyclingifyoudonotseeaproduct.Analyzeyoursample(s),alongwithsuitableDNAsizemarkers,byelectrophoresisonasuitableagarosegelcontaining0.1µg/mlEtBr.ThepercentageagaroseandtheDNAsizemarkersyouchoosewilldependontheexpectedrangeofinsertsizes.Youmaywishtorefertothefollowinggeneralguidelinesbeforeassemblingyourgel.
Recommendationsforagarosegels:
D. Using 10X Advantage 2 SA PCR Buffer Incaseswherenon-specificbackgroundamplificationisaproblem,we
stronglyrecommendthe10XAdvantage2SAPCRBufferbeusedasthebufferofchoice.
V. Advantage® 2 PCR Procedure continued
Expectedinsertsizerange
Recommended%agarose
RecommendedDNAsizemarkers
0.3–1.5kb 1.5 φX174/Hae III
0.5–10kb 1.2 1kbDNAladder
>5kb 0.8 λ/HindIII
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 15
Advantage® 2 PCR Enzyme System User Manual
Yieldsareunaffectedwhenamplifyingproducts lessthan2kb,whetherthe10XAdvantage2SAPCRBufferor theAdvantage2PCRBuffer isused.Werecommendinitialuseofthe10XAdvantage2PCRBuffer;andifbackgroundamplificationarises, inparticularwithampliconslessthan2kbinlength,thenwerecommendswitchingtothe10XAdvantage2SAPCRBuffer.
V. Advantage® 2 PCR Procedure continued
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 16 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
The followinggeneral guidelinesapply tomostPCR reactions.However,noattempthasbeenmadetoaddresstroubleshootingforallofthemanyapplica-tionsforwhichtheAdvantage2PolymeraseMixcanbeused.WhenusingtheenzymewithoneofClontechcompanionproducts,additionalapplication-specifictroubleshootinginformationcanbefoundintherelevantUserManual.
A. No product observed PCRcomponent Useachecklistwhenassemblingreactions.Always missingordegraded performapositivecontroltoensurethateachcom-
ponentisfunctional.Ifthepositivecontroldoesnotwork,repeatthepositivecontrolonly.Ifthepositivecontrol still does not work, repeat again replacingindividualcomponentstoidentifythefaultyreagent.
Toofewcycles Increasethenumberofcycles(3–5additionalcyclesatatime).
Annealingtemp. Decreasetheannealingtemperatureinincrements toohigh of2–4°C.
Suboptimalprimer Redesignyourprimer(s)afterconfirmingtheaccu- design racy of the sequence information. If the origi-
nal primer(s) was less than 22 nt long, try us-ing a longer primer. If the original primer(s) hada G-C content of less than 45%, try to designaprimerwithaG-Ccontentof45–60%.
Notenough RepeatPCRusingahigher concentrationofDNA template (aftertryingmorecycles).
Poortemplate Check template integrity by electrophoresis on a quality standardTBE-agarosegel.Ifnecessary,repurifyyour
templateusingmethodsthatminimizeshearingandnicking.
Denaturationtemp. Optimizedenaturationtemperaturebydecreasingor toohighorlow increasingitin1°Cincrements.(Adenaturationtem-
peraturethatistoohighcanleadtodegradationofthetemplate,especiallyforlongtargetsequences.)
Denaturationtime Optimizedenaturationtimebydecreasingorincreas- toolongortooshort ingitin10secincrements.(Adenaturationtimethat
istoolongcanleadtodegradationofthetemplate,especiallyforlongtargetsequences.)
Extensiontimetoo Especially for longer templates, increase the short extensiontimein1minincrements.
VI. Troubleshooting Guide
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 1�
Advantage® 2 PCR Enzyme System User Manual
Toolittleenzyme TheAdvantage2PolymeraseMixis50Xformostap-plications;howevera1Xfinalreactionconcentrationoftheenzymemixmaybetoolowforsomeapplications.Therefore, try tooptimize thecycleparametersasdescribedabovebeforeincreasingtheenzymecon-centration.Inrarecases,theyieldscanbeimprovedbyincreasingtheconcentrationoftheenzymemix.However,increasingthefinalconcentrationto>2Xinthereactionmixislikelytoleadtohigherbackgroundlevels.
[Mg2+]istoolow TheAdvantage2PolymeraseMixperformswellatabroadrangeofMg2+concentration.Therefore,aslongasyouusethebufferincludedwiththemixandafinalconcentrationof0.2mMofeachdNTP,it isunlikelythatalackofproductisduetoproblemswiththeMg2+concentration.However,highconcentrationsofEDTAorothermetalchelatorsinthetemplatestocksolution can reduce the effective concentration ofMg2+tobelowaminimumlevel.
[dNTPs]istoolow When used as recommended, the 50X dNTP mixprovidedwith thekitgivesafinal concentrationof0.2mMofeachdNTP.Inourexperience,thiscon-centrationofdNTPsissuitableforawiderangeofapplications.
IfyouarepreparingyourowndNTPs,besurethatyourfinalconcentrationofeachdNTPinthereactionis0.2mM.
Somemanufacturersrecommendusingconcentra-tionshigherthan0.2mMofeachdNTPwhenam-plifyinglargetemplates.However,wehavehadnotroubleamplifyinglargetemplatesusing0.2mMforeachdNTP.Sincewehavegoneupto35kbwiththeAdvantageGenomicPCRKit,itisunlikelythatdNTPsarelimiting.NotethatifyouincreasetheconcentrationofdNTPs,youwillalsoneedtoincreasethe[Mg2+]proportionately.
Difficulttarget Sometargetsareinherentlydifficulttoamplify.Inmostcases,thisisduetounusuallyhighG-Ccontentand/orsecondarystructure.UseAdvantageGCPolymeraseMixorKitinsteadoftheAdvantage2system.
VI. Troubleshooting Guide continued
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 18 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
B. Multiple products Toomanycycles Reducingthecyclenumbermayeliminatenonspecific
bands.
Annealingtemp. Increase the annealing/extension temperature in toolow incrementsof2–3°C. Suboptimalprimer Redesignyourprimer(s)afterconfirmingtheaccu- design racy of the sequence information. If the original
primer(s)waslessthan22ntlong,tryusingalongerprimer. If theoriginalprimer(s)hadaG-Ccontentoflessthan45%,trytodesignaprimerwithaG-Ccontentof45–60%.
TouchdownPCR “Touchdown”PCRsignificantlyimprovesthespeci- needed ficityofmanyPCRreactionsinvariousapplications
(Donet al.,1991;Roux,1995).TouchdownPCRin-volvesusinganannealing/extensiontemperaturethatisseveraldegreeshigherthantheTmoftheprimersduringtheinitialPCRcycles.Theannealing/extensiontemperatureisthenreducedtotheprimerTmfortheremainingPCRcycles.Thechangecanbeperformedeitherinasinglesteporinincrementsoverseveralcycles.
Contamination SeeSectionEbelow.
C. Low yield Poortemplate Check template integrity by electrophoresis on a quality standardTBE-agarosegel.Ifnecessary,repurifyyour
templateusingmethodsthatminimizeshearingandnicking.
D. Products are smeared on gel Toomanycycles Reducethecyclenumberby3–5toseeifnon-specific
bandsgoaway.
Denaturationtemp. Tryincreasingthedenaturationtemperatureinincre- toolow mentsof1°C.
Extensiontime Decreasetheextensiontimein1–2-minincrements. toolong
Poortemplate Checktemplateintegritybyelectrophoresisonade- quality denaturing agarose gel. Repurify your template if
necessary.
TouchdownPCR See “Touchdown PCR needed” under previous needed section.
VI. Troubleshooting Guide continued
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 1�
Advantage® 2 PCR Enzyme System User Manual
Non-specific Use the 10X Advantage SA PCR Buffer priming whichhasbeenspecificallyengineeredtoaddress
this(ratherthanthe10XAdvantage2PCRBuffer).
Toomuchenzyme TheAdvantage2PolymeraseMix is50X formostapplications;however,a1Xfinalconcentrationoftheenzymemixmaybetoohighforsomeapplications.Ifsmearingisobserved,firsttryoptimizingthecycleparametersasdescribedabove, then try reducingtheenzymeconcentrationto0.5–0.2X.
Toomuchtemplate TryalowerconcentrationofDNAtemplateinthePCRreaction.
Contamination SeeSectionEbelow.
E. Dealing with contamination Contaminationmostoftenresultsinextrabandsorsmearing.Itisimportant
toincludeanegativecontrol(acontrolthatreplacestheDNAtemplatewithPCR-gradeH2Obutstillincludestheprimers)ineveryPCRexperimenttodetermineifthePCRreagents,pipettorsorPCRreactiontubesarecon-taminatedwithpreviouslyamplifiedtargets.
Ifpossible,setupthePCRreactionandperformthepost-PCRanalysisinseparatelaboratoryareaswithseparatesetsofpipettors.
Laboratorybenchesandpipettorshaftscanbedecontaminatedbydepuri-nation.Wipesurfaceswith1NHClfollowedby1NNaOH.Thenneutralizewithaneutralbuffer(e.g.,TrisorPBS)andrinsewithddH2O.
Weadviseusingcommerciallyavailableaerosol-freepipettetips. AnenzymaticmethodhasbeenpublishedfordestroyingPCRproductcar-
ryover(Longoet al.,1990).ItinvolvesincorporationofdUTPintothePCRproductsandsubsequenthydrolysiswithuracil-N-glycosylase(UNG).
WhenperformingPCRdirectlyonphageplaquesorbacterialcolonies,failuretoisolatesingleplaquesorcolonieswillalsoproducemultiplebands.
VI. Troubleshooting Guide continued
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 20 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
ForacompletelistingofallClontechproducts,pleasevisitwww.clontech.com
PCR Products Cat. No.
• Sprint™TITANIUM™Taq384Plate 639552
• Sprint™Advantage®96Plate 639550
• Sprint™Advantage®SingleShots 639556 639553 639554
• 10XAdvantage2PCRBuffer 639137 639138
• TITANIUM™TaqDNAPolymerase 639208 639209
• TITANIUM™TaqPCRKit 639211 639210
• Advantage®GenomicPolymeraseMix 639110
VII. References
Barnes,W.M.(1994)PCRamplificationofupto35-kbDNAwithhighfidelityandhighyieldfromλbacteriophagetemplates.Proc. Natl. Acad. Sci. USA 91:2216–2220.
Cheng,S.,Fockler,C.,Barnes,W.M.&Higuchi,R.(1994)EffectiveamplificationoflongtargetsfromclonedinsertsandhumangenomicDNA.Proc. Natl. Acad. Sci. USA 91:5695–5699.
Don,R.H.,Cox,P.T.,Wainwright,B.J.,Baker,K.&Mattick,J.S.(1991)‘Touchdown’PCRtocir-cumventspuriousprimingduringgeneamplification.Nucleic Acids Res. 19:4008.
Frey,B.&Suppmann,B.(1995)DemonstrationoftheExpand™PCRsystem’sgreaterfidelityandhigheryieldswithalacI-basedPCRfidelityassay.Biochemica2:8–9.
Kellogg, D. E., Rybalkin, I., Chen, S., Mukhamedova, N., Vlasik,T., Chenchik,A. & Siebert, P.(1994)TaqStart:ANeutralizingMonoclonalAntibodythatfacilitates“HotStart”PCR.Clontechniques IX(2):1–5.
Kellogg,D.E.,Rybalkin,I.,Chen,S.,Mukhamedova,N.,Vlasik,T.,Siebert,P.&Chenchik,A.(1994)TaqStartAntibody:HotstartPCRfacilitatedbyaneutralizingmonoclonalantibodydirectedagainstTaq DNApolymerase.BioTechniques 16:1134–1137.
Longo,M.C.,Berninger,M.S.&Hartley,J.L.(1990)UseofuracilDNAglycosylasetocontrolcarry-overcontaminationinpolymerasechainreactions.Gene93:3749.
Nelson,K.,Brannan, J.&Kretz,K., (1995)The fidelity ofTaqPlus™DNAPolymerase inPCR.Strategies Mol. Biol. 8:24–25.
Roux,K.H.(1995)OptimizationandtroubleshootinginPCR.PCR Methods Appl.4:5185–5194.
Sambrook,J.&D.W.(2001)Molecular Cloning: A Laboratory Manual, Third Edition (ColdSpringHarborLaboratory,ColdSpringHarbor,NY).
VIII. Related Products
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 21
Advantage® 2 PCR Enzyme System User Manual
VIII. Related Products continued
PCR Products continued Cat. No.
• Advantage®GenomicPCRKit 639104 639103
• Advantage®GC2PolymeraseMix 639114
• Advantage®GC2PCRKit 639120 639119
• Advantage®GCGenomicPolymeraseMix 639113
• Advantage®GCGenomicPCRKit 639118 639117
• Advantage®HF2PCRKit 639124 639123
• Advantage®UltraPurePCR DeoxynucleotideMix 639125
• Advantage®UltraPure dNTPCombinationKit 639132
• TaqStart®Antibody 639250 639251 PCR Amplification Kits & Products
• SMART™cDNALibraryConstructionKit 634901
• SuperSMART™PCRcDNASynthesisKit 635000
• SMART™RACEcDNAAmplificationKit 634914
• Marathon®cDNAAmplificationKit 634913
• Marathon-ReadycDNAs many
• ClontechPCR-Select™ cDNASubtractionKit 637401
• ClontechPCR-Select™BacterialGenome SubtractionKit 637404• LD-InsertScreeningAmplimerSets many• RT-PCRAmplimerSets many
• Advantage®RT-for-PCRKit 639505 639506
• MTC™MultipleTissuecDNAPanels many
• QUICK-Clone™cDNAs many• TITANIUM™One-StepRT-PCRKit 639503 639504
Clontech Laboratories, Inc. www.clontech.com Protocol No. PT3281-1 22 Version No. PR621512
Advantage® 2 PCR Enzyme System User Manual
Notes
Protocol No. PT3281-1 www.clontech.com Clontech Laboratories, Inc. Version No. PR621512 23
Advantage® 2 PCR Enzyme System User Manual
Notes
Notice to PurchaserThisproduct is intended tobeused for researchpurposesonly. It isnot tobeused fordrugordiagnostic purposes nor is it intended for human use. Clontech products may not be resold,modified for resale, or used to manufacture commercial products without written approval ofClontechLaboratories,Inc..
Advantage®2productsarecoveredbyU.S.PatentNo.5,436,149.
Clontech™PCR-Select™cDNASubtractionproductsarecoveredbyU.S.PatentNos.5,565,340and5,759,822,aswellaspendingforeignpatentapplications.For-profitandnot-for-profitpurchas-ersofPCR-Selectproductsareentitled touse thereagents for research, including identificationofmolecularmarkersordifferentiallyexpressedgenes;however,thefollowingusesexpresslyareprohibited: (1)performingservices for thirdparties; (2) identifyingnucleicacid sequences tobeincludedonnucleicacidarrays,blots,orinlibrariesorothercDNAcollectionswhicharethensoldtothirdparties;or(3)constructingdatabaseswhicharethensoldtothirdparties.Further,reproduction,amplification,modification,reformulation,orresaleofthereagentsprovidedinPCR-Selectproductsisnotpermitted.ForinformationonlicensingPCR-Selectforthesepurposes,pleasecontact:ClontechLaboratories,Inc.,BusinessDevelopment,1290TerraBellaAvenue,MountainView,CA,94043orcalltheLicensingHotlineat650.919.7320ore-maillicensing@clontech.com.
TaqStart®AntibodyislicensedunderU.S.PatentNo.5,338,671.AlicenseunderU.S.patentNos.4,683,202,4,683,195and4,965,188ortheirforeigncounterpartsownedbyRocheMolecularSystems, Inc.andF.Hoffmann-LaRocheLtd. (“Roche”), foruse inresearchanddevelopment,hasanup-frontfeecomponentandarunning-royaltycomponent.BypurchasingcertainAppliedBiosystemsPCRreagents,purchasersobtainlimited,nontransferablerightsundertherunningroyaltycomponenttousethepurchasedamountofreagentstopracticethePolymeraseChainReaction(PCR)andrelatedprocessesdescribedinsaidpatentsonlyforresearchanddevelopmentactivitiesofthepurchaser.Suchuseisfullylicensedunderthesepatentsonlywhenthereagentsareusedinconjunctionwithathermalcyclerwhoseuseiscoveredbytheup-frontfeecomponent.Rightsundertheup-frontfeecomponentofaPCRlicensemaybepurchasedfromAppliedBiosystemsorobtainedbypurchasinganAuthorizedThermalCycler.NorighttoperformoroffercommercialservicesofanykindusingPCR,including,forexample,reportingtheresultsofpurchaser’sactivitiesforafeeorothercommercialconsideration,isgrantedunlessthepurchaserobtainsafurtherlicensefromeitherAppliedBiosystemsorRoche.Additionalinformationonpurchas-inglicensestopracticethePCRprocessmaybeobtainedbycontactingtheDirectorofLicensingatAppliedBiosystems,850LincolnCentreDrive,FosterCity,California94404orRocheMolecularSystems,1145AtlanticAvenue,Alameda,California,94501.
GeneAmp®isaregisteredtrademarkofRocheMolecularSystems,Inc., licensedtotheAppleraCorporation.Clontech,ClontechlogoandallothertrademarksarethepropertyofClontechLaboratories,Inc.ClontechisaTakaraBioCompany.©2006